PolyPid Ltd. (PYPD)
5.10
+0.12
(+2.31%)
USD |
NASDAQ |
Aug 25, 16:00
4.57
-0.53
(-10.39%)
Pre-Market: 08:59
PolyPid Net Income (Quarterly) : -7.849M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.849M |
| March 31, 2026 | -7.728M |
| December 31, 2025 | -8.473M |
| September 30, 2025 | -7.451M |
| June 30, 2025 | -9.977M |
| March 31, 2025 | -8.268M |
| December 31, 2024 | -8.52M |
| September 30, 2024 | -7.76M |
| June 30, 2024 | -6.294M |
| March 31, 2024 | -6.448M |
| December 31, 2023 | -6.356M |
| September 30, 2023 | -5.604M |
| June 30, 2023 | -5.837M |
| March 31, 2023 | -6.068M |
| December 31, 2022 | -6.535M |
| Date | Value |
|---|---|
| September 30, 2022 | -9.271M |
| June 30, 2022 | -11.84M |
| March 31, 2022 | -11.87M |
| December 31, 2021 | -13.23M |
| September 30, 2021 | -9.935M |
| June 30, 2021 | -10.48M |
| March 31, 2021 | -8.687M |
| December 31, 2020 | -7.549M |
| September 30, 2020 | -6.458M |
| June 30, 2020 | -16.99M |
| March 31, 2020 | -5.869M |
| December 31, 2019 | |
| September 30, 2019 | -2.108M |
| June 30, 2019 | 0.293M |
| March 31, 2019 | -1.23M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Teva Pharmaceutical Industries Ltd. | -585.89M |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | -7.392M |
| Purple Biotech Ltd. | 0.4486M |
| Sol-Gel Technologies Ltd. | -3.681M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 7.849M |
| EPS Diluted (Quarterly) | -0.3467 |
| Enterprise Value | 98.39M |
| Earnings Yield | -29.06% |
| Normalized Earnings Yield | -29.06 |